Primary biliary cholangitis trials in China

In China 16 Also abroad 41

16 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis
Where
Beijing, Changchun, Chengdu, Chongqing, Fuzhou, Guangzhou, Guiyang, Hefei, Kunming, Nanjing, Shanghai, Ürümqi, Wuhan, Xi'an, Xi’an, Zhejiang, Zhengzhou, Zhenjiang
Age
18 years and over
People
402 worldwide
Run by
Gilead Sciences
See details and how to joinNCT06051617 · EU 2024-516525-31-01
Phase 3Taking people
FIREFLY Trial: Fenofibrate Intervention---Randomized Evaluation in First-Line PBC Therapy
Where
Guangzhou, Xi'an
Age
18 years to 75 years
People
132
Run by
Xijing Hospital of Digestive Diseases
See details and how to joinNCT07296458
Phase 3Taking people
Fenofibrate for Patients With Primary Biliary Cirrhosis Who Had An Inadequate Response to Ursodeoxycholic Acid
Where
Xi'an
Age
18 years to 70 years
People
104
Run by
Xijing Hospital of Digestive Diseases
See details and how to joinNCT02823366
Phase 2/3Taking people
Fenofibrate in Patients With Primary Biliary Cholangitis (PBC)
Where
Xi'an
Age
18 years to 75 years
People
117
Run by
Xijing Hospital of Digestive Diseases
See details and how to joinNCT06365424
Phase 2/3Enrolling by invitation
A Multicenter, Randomized, Controlled Trial of Prednisone Combined With Ursodeoxycholic Acid in the Treatment of Primary Biliary Cholangitis With Moderate to Severe Interface Hepatitis Characteristics
Where
Guangzhou, Xi'an
Age
18 years to 75 years
People
244
Run by
Han Ying
See details and how to joinNCT06591468
Phase 1/2Not yet taking people in China
Phase I/II Trial of Human Umbilical Cord Mesenchymal Stromal Cells for UDCA-Refractory Primary Biliary Cholangitis
Where
Beijing
Age
18 years to 75 years
People
68
Run by
Beijing 302 Hospital
See details and how to joinNCT07795151
No phaseNot yet taking people in China
Study on Clinical and Pathological Features of Primary Biliary Cholangitis and Risk Factors Related to Disease Progression
Where
Beijing
Age
18 years and over
People
300
Run by
Beijing Municipal Administration of Hospitals
See details and how to joinNCT07733882
Phase 3Taking people
A Study of CS0159 in Patients With PBC With Inadequate Response or Intolerance to UDCA
Where
Baoji, Beijing, Changchun, Changsha, Chengdu, Chongqing, Fuzhou, Hangzhou, Harbin, Hefei, Linyi, Nanchang, Nanjing, Nanning, Ningbo, Qingdao, Shanghai, Shenyang, Shenzhen, Shiyan, Suzhou, Taizhou, Tianjin, Wuhan, Wuxi, Xiamen, Xi’an, Xining, Zhanjiang, Zhengzhou, Zhenjiang
Age
18 years to 75 years
People
135
Run by
Cascade Pharmaceuticals, Inc
See details and how to joinNCT07282353
Phase 2Not yet taking people in China
The Safety and Efficacy of Upadacitinib in Refractory Autoimmune Related Cholangitis and Atopic Dermatitis With Moderate to Severe Itching
Where
Shanghai
Age
18 years to 70 years
People
44
Run by
RenJi Hospital
See details and how to joinNCT07678645
No phaseTaking people
Biochemical Response and Clinical Outcomes in Patients With PBC
Where
Shanghai
Age
18 years to 85 years
People
3,000
Run by
RenJi Hospital
See details and how to joinNCT07449793
Phase 2/3Taking people
Fenofibrate for Compensated Cirrhosis Patients With Primary Biliary Cholangitis
Where
Beijing, Changsha, Chengdu, Guangzhou, Kunming, Nanjing, Shenyang, Tianjin, Xi'an, Yan’an, Zhengzhou
Age
18 years to 75 years
People
104
Run by
Xijing Hospital of Digestive Diseases
See details and how to joinNCT05749822
Phase 3Taking people
Fenofibrate Combined With Ursodeoxycholic Acid in Subjects With Primary Biliary Cholangitis
Where
Chengdu, Guangzhou, Lanzhou, Nanjing, Shenyang, Tianjin, Xi'an
Age
18 years to 75 years
People
150
Run by
Xijing Hospital of Digestive Diseases
See details and how to joinNCT05751967
Phase 3Taking people
Fenofibrate in Primary Biliary Cholangitis: a Real World Study
Where
Xi'an
Age
18 years to 75 years
People
300
Run by
Xijing Hospital of Digestive Diseases
See details and how to joinNCT06755151
Phase 3Taking people
Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cholangitis: a Real World Study
Where
Xi'an
Age
18 years to 75 years
People
150
Run by
Xijing Hospital of Digestive Diseases
See details and how to joinNCT06755541
No phaseTaking people
PBC Long-term Outcomes Study
Where
Beijing
People
4,000
Run by
Beijing Friendship Hospital
See details and how to joinNCT07149675
Phase 4Taking people
Clinical Research of Tapering UDCA in PBC Patients With a Complete Response
Where
Beijing
Age
18 years and over
People
90
Run by
Peking Union Medical College Hospital
See details and how to joinNCT04650243